Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma

American Journal of Pathology

Volumn 179, Issue 4, 2011, Pages 2108-2119

  Roy, Debasmita ^a   Dittmer, Dirk P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN P53; PROTEIN S6; SERINE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 10; CLINICAL EVALUATION; COLONY FORMATION; CONTROLLED STUDY; DELETION MUTANT; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPOSI SARCOMA; PHOSPHORYLATION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SOLID TUMOR; TISSUE MICROARRAY; TUMOR BIOPSY; TUMOR XENOGRAFT;

ANIMALS; BIOPSY; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, PRIMARY EFFUSION; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PHOSPHOSERINE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RIBOSOMAL PROTEIN S6; SARCOMA, KAPOSI; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80053269063     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.06.017     Document Type: Article

References (91)

1. E. Cesarman, Y. Chang, P.S. Moore, J.W. Said, and D.M. Knowles Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas N Engl J Med 332 1995 1186 1191
2. A.Y. Matsushima, J.A. Strauchen, G. Lee, E. Scigliano, E.E. Hale, M.T. Weisse, D. Burstein, O. Kamel, P.S. Moore, and Y. Chang Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus Am J Surg Pathol 23 1999 1393 1400 (Pubitemid 29517333)
3. G. Dotti, R. Fiocchi, T. Motta, B. Facchinetti, B. Chiodini, G.M. Borleri, G. Gavazzeni, T. Barbui, and A. Rambaldi Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8 Leukemia 13 1999 664 670 (Pubitemid 29243615)
4. R.G. Nador, E. Cesarman, A. Chadburn, D.B. Dawson, M.Q. Ansari, J. Sald, and D.M. Knowles Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus Blood 88 1996 645 656 (Pubitemid 26240396)
5. M.G. Horenstein, R.G. Nador, A. Chadburn, E.M. Hyjek, G. Inghirami, D.M. Knowles, and E. Cesarman Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 Blood 90 1997 1186 1191 (Pubitemid 27314155)
6. Y. Chang, E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, and P.S. Moore Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
7. G. Stallone, A. Schena, B. Infante, S. Di Paolo, A. Loverre, G. Maggio, E. Ranieri, L. Gesualdo, F.P. Schena, and G. Grandaliano Sirolimus for Kaposi's sarcoma in renal-transplant recipients N Engl J Med 352 2005 1317 1323 (Pubitemid 40411498)
8. E. Guenova, G. Metzler, W. Hoetzenecker, M. Berneburg, and M. Rocken Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment Arch Dermatol 144 2008 692 693 (Pubitemid 351724445)
9. S. Yaich, S. Zagdane, K. Charfeddine, D. Hssairi, and J. Hachicha Simultaneous Hodgkin's disease and Kaposi sarcoma in a renal transplant recipient Saudi J Kidney Dis Transpl 21 2010 306 309
10. C.M. Ho, S.F. Huang, R.H. Hu, M.C. Ho, Y.M. Wu, and P.H. Lee Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient Clin Transplant 24 2010 127 132
11. H.A. Yuksekkaya, C. Arikan, A. Yazici, M. Baran, S. Aydogdu, and M. Kilic Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus Pediatr Transplant 13 2009 375 378
12. M. Boratyska, S.C. Zmonarski, and M. Klinger Reccurence of Kaposi's sarcoma after increased exposure to sirolimus Int Immunopharmacol 6 2006 2018 2022 (Pubitemid 44855709)
13. O. Merimsky, I. Jiveliouk, and R. Sagi-Eisenberg Targeting mTOR in HIV-negative classic Kaposi's sarcoma Sarcoma 2008 2008 825093
14. N. Babel, N. Eibl, C. Ulrich, G. Bold, A. Sefrin, M.H. Hammer, C. Rosenberger, and P. Reinke Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod Transpl Infect Dis 10 2008 59 62 (Pubitemid 351171313)
15. E. Boulanger, P.V. Afonso, Y. Yahiaoui, H. Adle-Biassette, J. Gabarre, and F. Agbalika Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin Am J Transplant 8 2008 707 710 (Pubitemid 351287542)
16. B. Descoeudres, O. Giannini, T. Graf, J. Steiger, and M. Mayr No effect of sirolimus for Kaposi sarcoma in a renal transplant recipient Transplantation 81 2006 1472 1474 (Pubitemid 43847162)
17. P. Barozzi, G. Riva, D. Vallerini, R. Bosco, C. Quadrelli, E. Zanetti, L. Potenza, F. Forghieri, G. Torelli, and M. Luppi Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients Transplantation 88 2009 597 598
18. B.D. Kahan Sirolimus: a comprehensive review Expert Opin Pharmacother 2 2001 1903 1917 (Pubitemid 33069483)
19. M. Cully, H. You, A.J. Levine, and T.W. Mak Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis Nat Rev Cancer 6 2006 184 192 (Pubitemid 43292562)
20. N. Hay The Akt-mTOR tango and its relevance to cancer Cancer Cell 8 2005 179 183 (Pubitemid 41317589)
21. D.M. Sabatini mTOR and cancer: insights into a complex relationship Nat Rev Cancer 6 2006 729 734 (Pubitemid 44286004)
22. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39 (Pubitemid 28458022)
23. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501 (Pubitemid 37328931)
24. D.R. Carrasco, T. Fenton, K. Sukhdeo, M. Protopopova, M. Enos, M.J. You, D. Di Vizio, C. Nogueira, J. Stommel, G.S. Pinkus, C. Fletcher, J.L. Hornick, W.K. Cavenee, F.B. Furnari, and R.A. Depinho The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans Cancer Cell 9 2006 379 390 (Pubitemid 43668730)
25. T.F. Cloughesy, K. Yoshimoto, P. Nghiemphu, K. Brown, J. Dang, S. Zhu, T. Hsueh, Y. Chen, W. Wang, D. Youngkin, L. Liau, N. Martin, D. Becker, M. Bergsneider, A. Lai, R. Green, T. Oglesby, M. Koleto, J. Trent, S. Horvath, P.S. Mischel, I.K. Mellinghoff, and C.L. Sawyers Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma PLoS Med 5 2008 e8
26. T. Hyun, A. Yam, S. Pece, X. Xie, J. Zhang, T. Miki, J.S. Gutkind, and W. Li Loss of PTEN expression leading to high Akt activation in human multiple myelomas Blood 96 2000 3560 3568
27. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M.H. Wigler, and R. Parsons PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947 (Pubitemid 27148818)
28. M.S. Neshat, I.K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J.J. Gibbons, H. Wu, and C.L. Sawyers Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proc Natl Acad Sci USA 98 2001 10314 10319 (Pubitemid 32803017)
29. D.D. Sarbassov, S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, A.F. Bagley, A.L. Markhard, and D.M. Sabatini Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol Cell 22 2006 159 168
30. L.S. Steelman, P.M. Navolanic, M.L. Sokolosky, J.R. Taylor, B.D. Lehmann, W.H. Chappell, S.L. Abrams, E.W. Wong, K.M. Stadelman, D.M. Terrian, N.R. Leslie, A.M. Martelli, F. Stivala, M. Libra, R.A. Franklin, and J.A. McCubrey Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors Oncogene 27 2008 4086 4095 (Pubitemid 351931994)
31. C.J. Chang, D.J. Mulholland, B. Valamehr, S. Mosessian, W.R. Sellers, and H. Wu PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression Mol Cell Biol 28 2008 3281 3289 (Pubitemid 351657092)
32. J.L. Liu, Z. Mao, T.A. LaFortune, M.M. Alonso, G.E. Gallick, J. Fueyo, and W.K. Yung Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade Cancer Res 67 2007 11054 11063 (Pubitemid 350145936)
33. A. Gericke, M. Munson, and A.H. Ross Regulation of the PTEN phosphatase Gene 374 2006 1 9 (Pubitemid 43737118)
34. H.G. Wendel, A. Malina, Z. Zhao, L. Zender, S.C. Kogan, C. Cordon-Cardo, J. Pelletier, and S.W. Lowe Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo Cancer Res 66 2006 7639 7646 (Pubitemid 44289221)
35. S.H. Sin, D. Roy, L. Wang, M.R. Staudt, F.D. Fakhari, D.D. Patel, D. Henry, W.J. Harrington Jr, B.A. Damania, and D.P. Dittmer Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling Blood 109 2007 2165 2173 (Pubitemid 46348219)
36. B. Damania Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) Cell Biochem Biophys 40 2004 305 322
37. S. Montaner Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma Cell Cycle 6 2007 438 443 (Pubitemid 46393447)
38. C.C. Tomlinson, and B. Damania The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway J Virol 78 2004 1918 1927 (Pubitemid 38176723)
39. C. Boshoff, S.J. Gao, L.E. Healy, S. Matthews, A.J. Thomas, L. Coignet, R.A. Warnke, J.A. Strauchen, E. Matutes, O.W. Kamel, P.S. Moore, R.A. Weiss, and Y. Chang Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice Blood 91 1998 1671 1679 (Pubitemid 28110332)
40. E. Cesarman, P.S. Moore, P.H. Rao, G. Inghirami, D.M. Knowles, and Y. Chang In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences Blood 86 1995 2708 2714
41. L. Arvanitakis, E.A. Mesri, R.G. Nador, J.W. Said, A.S. Asch, D.M. Knowles, and E. Cesarman Establishment and characterization of a primary effusion (body cavity- based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus Blood 88 1996 2648 2654 (Pubitemid 26327517)
42. I. Guasparri, S.A. Keller, and E. Cesarman KSHV vFLIP is essential for the survival of infected lymphoma cells [Erratum appeared in J Exp Med 2006, 203:1383] J Exp Med 199 2004 993 1003 (Pubitemid 38481090)
43. K.V. Komanduri, J.A. Luce, M.S. McGrath, B.G. Herndier, and V.L. Ng The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions J Acquir Immune Defic Syndr Hum Retrovirol 13 1996 215 226
44. S.K. Ghosh, C. Wood, L.H. Boise, A.M. Mian, V.V. Deyev, G. Feuer, N.L. Toomey, N.C. Shank, L. Cabral, G.N. Barber, and W.J. Harrington Jr Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B Blood 101 2003 2321 2327 (Pubitemid 36302077)
45. J. Menezes, W. Leibold, G. Klein, and G. Clements Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma Biomedicine 22 1975 276 284
46. H. Ben-Bassat, N. Goldblum, S. Mitrani, T. Goldblum, J.M. Yoffey, M.M. Cohen, Z. Bentwich, B. Ramot, E. Klein, and G. Klein Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75) Int J Cancer 19 1977 27 33 (Pubitemid 8016922)
47. T. Crook, G.A. Parker, M. Rozycka, S. Crossland, and M.J. Allday A transforming p53 mutant, which binds DNA, transactivates and induces apoptosis reveals a nuclear: cytoplasmic shuttling defect Oncogene 16 1998 1429 1441 (Pubitemid 28151850)
48. J.S. Cannon, D. Ciufo, A.L. Hawkins, C.A. Griffin, M.J. Borowitz, G.S. Hayward, and R.F. Ambinder A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant J Virol 74 2000 10187 10193
49. H. Katano, Y. Hoshino, Y. Morishita, T. Nakamura, H. Satoh, A. Iwamoto, B. Herndier, and S. Mori Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma J Med Virol 58 1999 394 401 (Pubitemid 29326054)
50. C. Brander, T. Suscovich, Y. Lee, P.T. Nguyen, P. O'Connor, J. Seebach, N.G. Jones, M. van Gorder, B.D. Walker, and D.T. Scadden Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus J Immunol 165 2000 2077 2083 (Pubitemid 30648750)
51. W.A. van Hattem, L.A. Brosens, W.W. de Leng, F.H. Morsink, S. Lens, R. Carvalho, F.M. Giardiello, and G.J. Offerhaus Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis Gut 57 2008 623 627 (Pubitemid 351579974)
52. Y.H. Zhou, F. Tan, K.R. Hess, and W.K. Yung The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival Clin Cancer Res 9 2003 3369 3375 (Pubitemid 37082732)
53. W. Chen, I.B. Hilton, M.R. Staudt, C.E. Burd, and D.P. Dittmer Distinct p53, p53: LANA, and LANA complexes in Kaposi's sarcoma-associated herpesvirus lymphomas J Virol 84 2010 3898 3908
54. L.W. Ayers, S. Silver, M.S. McGrath, and J.M. Orenstein The AIDS and Cancer Specimen Resource: role in HIV/AIDS scientific discovery Infect Agent Cancer 2 2007 7
55. M.R. Staudt, Y. Kanan, J.H. Jeong, J.F. Papin, R. Hines-Boykin, and D.P. Dittmer The tumor microenvironment controls primary effusion lymphoma growth in vivo Cancer Res 64 2004 4790 4799 (Pubitemid 38924522)
56. R. Parsons Human cancer, PTEN and the PI-3 kinase pathway Semin Cell Dev Biol 15 2004 171 176 (Pubitemid 38251645)
57. F. Vazquez, S. Ramaswamy, N. Nakamura, and W.R. Sellers Phosphorylation of the PTEN tail regulates protein stability and function Mol Cell Biol 20 2000 5010 5018 (Pubitemid 30431555)
58. A. Carracedo, A. Alimonti, and P.P. Pandolfi PTEN level in tumor suppression: how much is too little? Cancer Res 71 2011 629 633
59. J.E. Kay, M.C. Smith, V. Frost, and G.Y. Morgan Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells Immunology 87 1996 390 395 (Pubitemid 26101265)
60. J.H. Chung, and C. Eng Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis Cancer Res 65 2005 8096 8100 (Pubitemid 41330571)
61. J.L. Liu, X. Sheng, Z.K. Hortobagyi, Z. Mao, G.E. Gallick, and W.K. Yung Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation Mol Cell Biol 25 2005 6211 6224 (Pubitemid 40946569)
62. S.M. Planchon, K.A. Waite, and C. Eng The nuclear affairs of PTEN J Cell Sci 121 2008 249 253 (Pubitemid 351356695)
63. D.H. Kedes, M. Lagunoff, R. Renne, and D. Ganem Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus J Clin Invest 100 1997 2606 2610 (Pubitemid 27514901)
64. G.R. Picchio, R.E. Sabbe, R.J. Gulizia, M. McGrath, B.G. Herndier, and D.E. Mosier The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft Virology 238 1997 22 29 (Pubitemid 27497258)
65. S. Uddin, A.R. Hussain, K.A. Al-Hussein, P.S. Manogaran, A. Wickrema, M.I. Gutierrez, and K.G. Bhatia Inhibition of phosphatidylinositol 3′-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells Clin Cancer Res 11 2005 3102 3108 (Pubitemid 40525217)
66. I.W. Cheney, D.E. Johnson, M.T. Vaillancourt, J. Avanzini, A. Morimoto, G.W. Demers, K.N. Wills, P.W. Shabram, J.B. Bolen, S.V. Tavtigian, and R. Bookstein Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer Cancer Res 58 1998 2331 2334 (Pubitemid 28252688)
67. A.M. Morimoto, A.E. Berson, G.H. Fujii, D.H. Teng, S.V. Tavtigian, R. Bookstein, P.A. Steck, and J.B. Bolen Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase Oncogene 18 1999 1261 1266 (Pubitemid 29094877)
68. C.E. Petre, S.H. Sin, and D.P. Dittmer Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy J Virol 81 2007 1912 1922 (Pubitemid 46214463)
69. B.G. Herndier, A. Werner, P. Arnstein, N.W. Abbey, F. Demartis, R.L. Cohen, M.A. Shuman, and J.A. Levy Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals AIDS 8 1994 575 581 (Pubitemid 24126114)
70. A. Albini, I. Paglieri, G. Orengo, S. Carlone, M.G. Aluigi, R. DeMarchi, C. Matteucci, A. Mantovani, F. Carozzi, S. Donini, and R. Benelli The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line AIDS 11 1997 713 721 (Pubitemid 27186940)
71. Y. Lunardi-Iskandar, P. Gill, V.H. Lam, R.A. Zeman, F. Michaels, D.L. Mann, M.S. Reitz Jr, M. Kaplan, Z.N. Berneman, D. Carter, J.L. Bryant, and R.C. Gallo Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma J Natl Cancer Inst 87 1995 974 981
72. F.Q. An, H.M. Folarin, N. Compitello, J. Roth, S.L. Gerson, K.R. McCrae, F.D. Fakhari, D.P. Dittmer, and R. Renne Long-term-infected telomerase- immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo J Virol 80 2006 4833 4846
73. P. Wlodarski, M. Kasprzycka, X. Liu, M. Marzec, E.S. Robertson, A. Slupianek, and M.A. Wasik Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum Cancer Res 65 2005 7800 7808 (Pubitemid 41297255)
74. M. Majewski, M. Korecka, P. Kossev, S. Li, J. Goldman, J. Moore, L.E. Silberstein, P.C. Nowell, W. Schuler, L.M. Shaw, and M.A. Wasik The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders Proc Natl Acad Sci USA 97 2000 4285 4290 (Pubitemid 30226125)
75. Z. Kaposztas, W.B. Etheridge, and B.D. Kahan Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus Transplant Proc 40 2008 1744 1746 (Pubitemid 351853149)
76. O. Cen, and R. Longnecker Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma Mol Cancer Ther 10 2011 679 686
77. B.B. Ma, V.W. Lui, E.P. Hui, C.P. Lau, K. Ho, M.H. Ng, S.H. Cheng, S.W. Tsao, and A.T. Chan The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines Invest New Drugs 28 2010 413 420
78. S.G. Holtan, L.F. Porrata, J.P. Colgan, C.S. Zent, T.M. Habermann, and S.N. Markovic mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD) Am J Hematol 83 2008 688 689
79. P.L. Dahia, R.C. Aguiar, J. Alberta, J.B. Kum, S. Caron, H. Sill, D.J. Marsh, J. Ritz, A. Freedman, C. Stiles, and C. Eng PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies Hum Mol Genet 8 1999 185 193 (Pubitemid 29054260)
80. T. Van de Sande, E. De Schrijver, W. Heyns, G. Verhoeven, and J.V. Swinnen Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells Cancer Res 62 2002 642 646 (Pubitemid 34126933)
81. A. Radu, V. Neubauer, T. Akagi, H. Hanafusa, and M.M. Georgescu PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1 Mol Cell Biol 23 2003 6139 6149 (Pubitemid 37013092)
82. E. Boulanger, A. Marchio, S.S. Hong, and P. Pineau Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma Haematologica 94 2009 1170 1174
83. R.T. Abbott, S. Tripp, S.L. Perkins, K.S. Elenitoba-Johnson, and M.S. Lim Analysis of the PI-3-kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray Mod Pathol 16 2003 607 612 (Pubitemid 36718443)
84. A.M. Al-Khouri, Y. Ma, S.H. Togo, S. Williams, and T. Mustelin Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta J Biol Chem 280 2005 35195 35202 (Pubitemid 41532706)
85. M. Fujimuro, and S.D. Hayward The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta J Virol 77 2003 8019 8030 (Pubitemid 36792798)
86. G.H. Kang, S. Lee, W.H. Kim, H.W. Lee, J.C. Kim, M.G. Rhyu, and J.Y. Ro Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma Am J Pathol 160 2002 787 794 (Pubitemid 34224568)
87. R. Hino, H. Uozaki, N. Murakami, T. Ushiku, A. Shinozaki, S. Ishikawa, T. Morikawa, T. Nakaya, T. Sakatani, K. Takada, and M. Fukayama Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma Cancer Res 69 2009 2766 2774
88. J. Dal Col, P. Zancai, L. Terrin, M. Guidoboni, M. Ponzoni, A. Pavan, M. Spina, S. Bergamin, S. Rizzo, U. Tirelli, A. De Rossi, C. Doglioni, and R. Dolcetti Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma Blood 111 2008 5142 5151
89. A. Silva, J.A. Yunes, B.A. Cardoso, L.R. Martins, P.Y. Jotta, M. Abecasis, A.E. Nowill, N.R. Leslie, A.A. Cardoso, and J.T. Barata PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability J Clin Invest 118 2008 3762 3774
90. G. Hess, R. Herbrecht, J. Romaguera, G. Verhoef, M. Crump, C. Gisselbrecht, A. Laurell, F. Offner, A. Strahs, A. Berkenblit, O. Hanushevsky, J. Clancy, B. Hewes, L. Moore, and B. Coiffier Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma J Clin Oncol 27 2009 3822 3829
91. G. Sarek, S. Kurki, J. Enbck, G. Iotzova, J. Haas, P. Laakkonen, M. Laiho, and P.M. Ojala Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas J Clin Invest 117 2007 1019 1028 (Pubitemid 46556758)